A study of transanal partial full-thickness resection and radical resection of rectal cancer in the treatment of stage IA rectal cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100051077

Enrollment

Unknown

Registered

2021-09-11

Start date

2021-09-01

Completion date

Unknown

Last updated

2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

transanal partial full-thickness resection vs. radical resection of rectal cancer:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. Those who are weak, have major diseases, are older, or have a strong desire to preserve their anus; 3. Colonoscopy: the lower edge of the tumor is less than or equal to 15cm from the anal verge, the pathology shows rectal adenocarcinoma, and high-grade intraepithelial neoplasia; 4. Rectal endoscopic ultrasonography, pelvic enhanced CT, rectal enhanced MRI: the lower edge of the tumor is <=15cm from the anal verge, the stage is T1 or below (initial assessment <=cT1N0M0 or reassessment after neoadjuvant therapy <=ycT1N0M0), no lymph node metastasis, no distant metastasis; 5. Concomitant diseases without absolute contraindications to surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of pelvic radiotherapy; 2. Patients with peritoneal implantation; 3. Refuse to participate in the researcher.

Design outcomes

Primary

Measure	Time frame
5-year overall survival;5-year disease-free survival;5-year local recurrence rate;	—

Countries

China

Contacts

Public ContactZhang Chaojun

Department of General Surgery, the First Medical Center, Chinese PLA General Hospital

zcjdlyxzx@163.com+86 18600317036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026